OA08720A - Activated RNase L as a maker for viral infections. - Google Patents

Activated RNase L as a maker for viral infections.

Info

Publication number
OA08720A
OA08720A OA59294A OA59294A OA08720A OA 08720 A OA08720 A OA 08720A OA 59294 A OA59294 A OA 59294A OA 59294 A OA59294 A OA 59294A OA 08720 A OA08720 A OA 08720A
Authority
OA
OAPI
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
OA59294A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08720A publication Critical patent/OA08720A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
OA59294A 1987-03-03 1988-03-03 Activated RNase L as a maker for viral infections. OA08720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (1)

Publication Number Publication Date
OA08720A true OA08720A (en) 1989-03-31

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59294A OA08720A (en) 1987-03-03 1988-03-03 Activated RNase L as a maker for viral infections.

Country Status (20)

Country Link
EP (1) EP0285263B1 (fr)
JP (1) JPH0675520B2 (fr)
KR (1) KR880011593A (fr)
AT (1) ATE107964T1 (fr)
AU (1) AU618525B2 (fr)
CA (1) CA1337278C (fr)
DE (1) DE3850428T2 (fr)
DK (1) DK112888A (fr)
ES (1) ES2058252T3 (fr)
FI (1) FI880959A7 (fr)
IE (1) IE66831B1 (fr)
IL (1) IL85576A0 (fr)
MX (1) MX173802B (fr)
NO (1) NO880934L (fr)
NZ (1) NZ223721A (fr)
OA (1) OA08720A (fr)
PH (1) PH30882A (fr)
PT (1) PT86878B (fr)
RU (1) RU2049336C1 (fr)
ZA (1) ZA881471B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306347B1 (fr) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnostic des déficiences en RNA double-brin
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
ES2066847T3 (es) * 1988-07-07 1995-03-16 Hem Pharma Corp Diagnostico y tratamiento del sindrome de fatiga cronica.
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
RU2202110C1 (ru) * 2001-07-26 2003-04-10 Научно-исследовательский испытательный центр (медико-биологической защиты) Государственного научно-исследовательского испытательного института военной медицины МО РФ Способ определения активности и функционального состояния синтетазы оксида азота
WO2017193051A1 (fr) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Procédés de surveillance de l'activité de rnase l

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
DE3850428T2 (de) 1994-11-24
PT86878B (pt) 1992-05-29
NO880934D0 (no) 1988-03-02
AU1256388A (en) 1988-09-01
PT86878A (pt) 1988-04-01
ZA881471B (en) 1988-12-28
EP0285263A2 (fr) 1988-10-05
CA1337278C (fr) 1995-10-10
NO880934L (no) 1988-09-05
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
ATE107964T1 (de) 1994-07-15
IE66831B1 (en) 1996-02-07
EP0285263B1 (fr) 1994-06-29
RU2049336C1 (ru) 1995-11-27
PH30882A (en) 1997-12-23
JPH0675520B2 (ja) 1994-09-28
NZ223721A (en) 1991-02-26
EP0285263A3 (en) 1990-04-18
FI880959A0 (fi) 1988-03-02
ES2058252T3 (es) 1994-11-01
DK112888D0 (da) 1988-03-02
IL85576A0 (en) 1988-08-31
FI880959A7 (fi) 1988-09-04
DK112888A (da) 1988-09-04
AU618525B2 (en) 1992-01-02
JPS63309200A (ja) 1988-12-16
DE3850428D1 (de) 1994-08-04
IE880587L (en) 1988-09-03

Similar Documents

Publication Publication Date Title
Player et al. The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
PH30882A (en) Activated Rnase L as a maker for viral infections.
AU6497694A (en) Method for selective inactivation of viral replication
GB2199328A (en) Translation of mrna
NZ228645A (en) 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
FI883763A0 (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
AU590817B2 (en) Antiviral combinations
TW366339B (en) Derivatives of benzimidazolyl-cyclopentanediol, -cyclopentanol and -cyclopentenol, and pharmaceutical composition containing the same
SE8601435L (sv) Aktivt pansar
EP0135713A3 (fr) Combinaisons anti-virales
IL85603A (en) Synergistic compositions of interleukin-2 and mismatched double- stranded rna
IE892060L (en) Antiviral combinations
ES2195370T3 (es) Procedimiento para la preparacion de 2`-fluoro-5-metil-beta-l-arabinofuranosiluridina.
DK615788D0 (da) Nucleosidforbindelser til anvendelse mod virale infektioner
ES2000853A6 (es) Proyectil portador para mortero
DE69324244D1 (de) Therapeutische nukleoside der 2',3'-dideoxy-3'-fluor -purin reihe
EP0034424A3 (fr) Composés contenant un noyau à sept chainons, comme inhibiteurs de cytidine déaminase
DE60128565D1 (en) Polycyclische xanthone als antibiotika
WO1988007080A3 (fr) Cellules animales transgeniques resistantes aux infections virales
EP0124884A3 (fr) Allumeur actionné par devant
ES8405381A1 (es) Un procedimiento para preparar compuestos derivados de 1,3,5-triacrilhexahidro-s-triazina.